P. Aguiar Júnior, C. M. N. Barreto, F. Roitberg, G. Lopes Júnior, and A. del Giglio, “Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study”, Sao Paulo Med J, vol. 137, no. 6, pp. 505–511, Dec. 2019.